Kayo Kunimoto

13PUBLICATIONS
72CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematologyAutoimmunityWastewater treatment processes
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 25, 2026
Efficacy, Safety, and Predictive Value of Quantitative Histopathology in Picosecond Laser Therapy for Congenital Melanocytic Nevi: A Prospective Clinical Trial.

|Jan 07, 2026
Genomic and transcriptomic analyses of melanoma in Japanese patients reveal candidate biomarkers for immune checkpoint inhibitor responders.

T Kimura, N Tanaka, T Maekawa

|Mar 05, 2025
Topical sirolimus therapy for cutaneous vascular anomalies: A randomized phase II clinical trial.

Masatoshi Jinnin, Toshio Shimokawa, Akiko Kishi

|Jan 28, 2025
Biomarkers associated with progression of infantile hemangioma: Exploratory study.

Ken Miyazaki, Kayo Kunimoto, Shiho Yasue

|Jan 03, 2025
Blood DNA virome associates with autoimmune diseases and COVID-19.

Noah Sasa, Shohei Kojima, Rie Koide

|Jun 27, 2023
Glycoprotein M6A upregulation detected by transcriptome analysis controls the proliferation of keloidal fibroblasts.

Mana Kurimoto-Nishiguchi, Kyoko Muraoka, Yutaka Inaba

Pageof 3

Frequent Collaborators

6 joint publications

Yuki Yamamoto

6 joint publications

Masatoshi Jinnin

3 joint publications

Chikako Kaminaka

3 joint publications

Mariko Sakata